Our Expert Team

All substance profiles, protocols, and research articles on BiohackingHub are reviewed and fact-checked by qualified medical professionals. Below are the credentials and specialisations of our editorial team.

Editorial Independence Policy

Our reviewers operate independently of commercial interests. Affiliate relationships are disclosed on all relevant pages. Reviewers do not receive compensation from supplement or peptide brands reviewed on this site. Read our full editorial policy →

AV

Dr. Aleksei Volkov, MD, PhD

Longevity & Peptide Therapy Reviewer
MD — First Moscow State Medical University (Sechenov University)PhD Gerontology — Institute of Bioregulation and Gerontology, St. Petersburg

Dr. Volkov trained at Sechenov University and completed his PhD under the supervision of Prof. Khavinson at the Institute of Bioregulation and Gerontology in St. Petersburg — the research institute responsible for developing epithalon, thymalin, and the foundational peptide bioregulator library. He has 12 years of clinical experience in longevity medicine and peptide therapy protocols, and brings direct knowledge of the Russian clinical literature that forms the evidence base for many bioregulator compounds. He joined BiohackingHub as Longevity & Peptide Therapy Reviewer in 2025.

Peptide bioregulators and Khavinson protocolsTelomere biology and epigenetic ageingmTOR inhibition and rapamycin longevity protocolsThymic restoration and immune rejuvenation
JS

Dr. Jane Smith, MD, PhD

Chief Medical Reviewer
MD — Johns Hopkins School of MedicinePhD Biochemistry — Stanford University

Dr. Smith completed her MD at Johns Hopkins and a PhD in Biochemistry at Stanford, with her doctoral research focused on telomerase regulation in human somatic cells. She has practised internal and preventive medicine for 14 years, with a clinical focus on longevity and metabolic optimisation. She joined BiohackingHub as Chief Medical Reviewer in 2025, responsible for ensuring all substance profiles and clinical protocols reflect current peer-reviewed evidence.

Longevity medicine & biological age reversalPeptide therapeutics and regulatory pharmacologyMitochondrial dysfunction and NAD+ biologyEvidence-based supplementation protocols
MC

Dr. Michael Chen, MD

Metabolic Medicine Reviewer
MD — University of California San Francisco (UCSF)Board Certified: Endocrinology, Diabetes & Metabolism (ABIM)

Dr. Chen completed his medical training at UCSF and fellowship at the Mayo Clinic, specialising in the metabolic underpinnings of obesity and type 2 diabetes. His clinical practice focuses on evidence-based pharmacological and lifestyle interventions for body composition, with particular expertise in GLP-1 agonist protocols, metabolic biomarker interpretation, and continuous glucose monitoring. He joined BiohackingHub as Metabolic Medicine Reviewer in 2025.

GLP-1 receptor agonists and incretin therapyMetabolic syndrome and insulin resistanceBody composition optimisation and fat loss pharmacologyCGM-guided nutrition and glucose variability
PN

Dr. Priya Nair, MD, MSc

Gastroenterology & Gut Health Reviewer
MD — All India Institute of Medical Sciences (AIIMS), New DelhiMSc Mucosal Immunology — University of Edinburgh

Dr. Nair completed her gastroenterology fellowship at Johns Hopkins after an MSc in Mucosal Immunology at Edinburgh, where her research focused on melanocortin receptor signalling in intestinal epithelial cells. Her clinical and research expertise spans leaky gut, IBD, and peptide-based mucosal repair protocols — including the mechanistic basis of BPC-157 and KPV in gastrointestinal healing. She joined BiohackingHub as Gastroenterology & Gut Health Reviewer in 2025.

Intestinal barrier function and tight junction biologyInflammatory bowel disease and mucosal immunologyGut microbiome and peptide-mediated repairMelanocortin signalling in gut inflammation
SO

Dr. Sarah Okonkwo, PhD

Neuroscience & Peptide Reviewer
PhD Neuroscience — MIT (Massachusetts Institute of Technology)Postdoctoral Research: Synaptic Plasticity, Salk Institute

Dr. Okonkwo completed her PhD at MIT studying synaptic plasticity mechanisms and conducted postdoctoral research at the Salk Institute on BDNF signalling in the hippocampus. Her research spans peptide pharmacokinetics across the blood-brain barrier, neuroplasticity mechanisms, and the neurobiology of dopamine depletion. She joined BiohackingHub as Neuroscience & Peptide Reviewer in 2025, focusing on cognitive enhancement and brain restoration compounds.

Peptide nootropics and synaptic plasticityBDNF, NGF, and neurotrophic factor biologyDopaminergic system restoration and neuroplasticityBlood-brain barrier pharmacokinetics
BH

BiohackingHub Research Team

Editorial Research Team
Multidisciplinary team: biochemistry, pharmacology, nutrition scienceEditorial standards aligned with Oxford Centre for Evidence-Based Medicine

The BiohackingHub Research Team comprises specialists in biochemistry, pharmacology, and evidence-based medicine. The team is responsible for primary literature review, Oxford Level grading, and initial drafting of all substance profiles, protocol guides, and research articles. All content passes peer review by Dr. Jane Smith before publication.

Systematic literature review and evidence gradingPeptide pharmacology and bioavailability researchClinical trial analysis and Oxford Level gradingSupplement industry quality control and COA verification